"Lipoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes.
| Descriptor ID |
D008074
|
| MeSH Number(s) |
D10.532 D12.776.521
|
| Concept/Terms |
Lipoproteins- Lipoproteins
- Lipoprotein
- Circulating Lipoproteins
- Lipoproteins, Circulating
|
Below are MeSH descriptors whose meaning is more general than "Lipoproteins".
Below are MeSH descriptors whose meaning is more specific than "Lipoproteins".
This graph shows the total number of publications written about "Lipoproteins" by people in this website by year, and whether "Lipoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 3 | 2 | 5 |
| 1996 | 1 | 2 | 3 |
| 1997 | 0 | 3 | 3 |
| 1998 | 5 | 0 | 5 |
| 1999 | 2 | 0 | 2 |
| 2000 | 5 | 1 | 6 |
| 2001 | 1 | 3 | 4 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 3 | 1 | 4 |
| 2005 | 2 | 2 | 4 |
| 2006 | 3 | 0 | 3 |
| 2007 | 1 | 1 | 2 |
| 2008 | 5 | 2 | 7 |
| 2009 | 1 | 2 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 5 | 2 | 7 |
| 2012 | 3 | 1 | 4 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 3 | 3 |
| 2019 | 2 | 1 | 3 |
| 2020 | 2 | 0 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipoproteins" by people in Profiles.
-
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments. Curr Atheroscler Rep. 2024 02; 26(2):35-44.
-
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial. JAMA. 2023 09 19; 330(11):1054-1063.
-
Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1. Crit Care. 2023 06 26; 27(1):250.
-
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content. JAMA Cardiol. 2022 Mar 01; 7(3):250-256.
-
Extracellular electron transfer increases fermentation in lactic acid bacteria via a hybrid metabolism. Elife. 2022 02 11; 11.
-
Pig and Mouse Models of Hyperlipidemia and Atherosclerosis. Methods Mol Biol. 2022; 2419:379-411.
-
Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2020 10; 31(5):286-290.
-
Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2020 02; 31(1):35-37.
-
Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice. Int J Mol Sci. 2019 Sep 14; 20(18).
-
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy. J Clin Lipidol. 2019 Nov - Dec; 13(6):997-1007.e8.